ICD10 code of Marshall syndrome - PFAPA and ICD9 code

TL;DR: Marshall syndrome, commonly known as PFAPA syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis), is classified under the ICD-10 code D89.89 (Other specified disorders involving the immune mechanism) and is historically associated with ICD-9 code 279.8. Because it is a clinical diagnosis without a single pathognomonic biomarker, these codes are used for administrative billing rather than defining the specific systemic inflammatory nature of the condition.

What is the clinical definition of Marshall syndrome (PFAPA)?

Marshall syndrome, or PFAPA syndrome, is a periodic fever syndrome characterized by recurrent episodes of high fever, aphthous stomatitis (canker sores), pharyngitis (sore throat), and cervical adenitis (swollen lymph nodes). Unlike many autoinflammatory diseases, Marshall syndrome typically presents in children before the age of 5. While the condition is self-limiting and children usually outgrow it, the frequent, predictable episodes can cause significant distress for families. At DiseaseMaps.org, we have seen 7 community members share their personal experiences with this condition, highlighting the need for accurate diagnostic coding to ensure proper clinical tracking.

How is Marshall syndrome (PFAPA) coded for medical billing?

Because there is no specific ICD-10 or ICD-9 code exclusively dedicated to Marshall syndrome (PFAPA), healthcare providers must use "umbrella" codes for autoinflammatory or immune-related disorders. The ICD-10 code D89.89 is the most common selection for Marshall syndrome, as it covers specified disorders involving the immune mechanism. In the older ICD-9 system, 279.8 served a similar purpose. It is important to note that these codes do not capture the periodic nature of the disease, which is why clinical documentation should always explicitly state "PFAPA syndrome" or "Marshall syndrome" in the patient’s medical record to ensure insurance coverage for necessary evaluations, such as ruling out other periodic fever syndromes like FMF (Familial Mediterranean Fever).

How do clinicians distinguish Marshall syndrome from other conditions?

The diagnosis of Marshall syndrome is primarily clinical, based on the criteria established by Marshall himself. To ensure accurate diagnosis and appropriate use of ICD-10 coding, physicians typically look for the following diagnostic markers:

• Recurrent Fevers: Episodes typically lasting 3 to 6 days occurring at regular intervals.


• Absence of Upper Respiratory Infection: Symptoms occur without the typical viral signs like cough or rhinorrhea.


• Clinical Triad: Presence of at least one of the following: aphthous stomatitis, cervical lymphadenitis, or pharyngitis.


• Treatment Response: A dramatic, rapid response to a single dose of corticosteroids, which is often used as a diagnostic tool for Marshall syndrome.


• Complete Well-being: Children are completely asymptomatic between episodes, showing normal growth and development.

Is there a genetic cause for Marshall syndrome (PFAPA)?

Unlike many other autoinflammatory conditions, there is no single identified gene mutation that definitively causes Marshall syndrome. While researchers suspect a complex, multifactorial inheritance pattern or an immune dysregulation, genetic testing is often used to exclude other periodic fever syndromes. When a child presents with symptoms of Marshall syndrome, genetic counselors may recommend testing for mutations in the MEFV, MVK, or TNFRSF1A genes to rule out conditions that require different management strategies.

Next steps

• Consult a pediatric rheumatologist or an immunologist to confirm the diagnosis of Marshall syndrome.


• Maintain a detailed fever diary to track the frequency and duration of episodes, which is essential for accurate clinical monitoring.


• Join the DiseaseMaps.org community to connect with other families managing Marshall syndrome and share insights on symptom management.


• Discuss with your physician whether a trial of tonsillectomy or specific immunomodulatory treatments is appropriate for your child’s case.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: PFAPA Syndrome.


• Orphanet: Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome (ORPHA:99929).


• OMIM (Online Mendelian Inheritance in Man): PFAPA Syndrome entry #612635.


• UpToDate: Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome.